Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis

Journal of Neuroimmunology

Volumn 222, Issue 1-2, 2010, Pages 70-75

  Camina Tato M ^a   Fernandez M ^a   Morcillo Suarez C ^b,c   Navarro, A ^b,d   Julia E ^a   Edo, M C ^a   Montalban, X ^a   Comabella, M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c National Institute for Bioinformatics INB   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Caspase 8; Multiple sclerosis; Polymorphisms

Indexed keywords

CASPASE 8;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASPASE 8; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 77952293566     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.03.003     Document Type: Article

References (31)

1. Achiron A., Gurevich M., Friedman N., Kaminski N., Mandel M. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann. Neurol. 2004, 55:410-417.
2. Baranzini S.E., Bernard C.C., Oksenberg J.R. Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis. J. Immunol. 2005, 174:7412-7422.
3. Barnhart B.C., Lee J.C., Alappat E.C., Peter M.E. The death effector domain protein family. Oncogene 2003, 22:8634-8644.
4. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
5. Carmody R.J., Hilliard B., Maguschak K., Chodosh L.A., Chen Y.H. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J. Neuroimmunol. 2002, 133:95-107.
6. Chervonsky A.V. Apoptotic and effector pathways in autoimmunity. Curr. Opin. Immunol. 1999, 11:684-688.
7. Chowdhury I., Tharakan B., Bhat G.K. Current concepts in apoptosis: the physiological suicide program revisited. Cell. Mol. Biol. Lett. 2006, 11:506-525.
8. Comabella M., Martin R. Genomics in multiple sclerosis-current state and future directions. J. Neuroimmunol. 2007, 187:1-8.
9. Comi C., Leone M., Bonissoni S., DeFranco S., Bottarel F., Mezzatesta C., Chiocchetti A., Perla F., Monaco F., Dianzani U. Defective T cell fas function in patients with multiple sclerosis. Neurology 2000, 55:921-927.
10. De Jager P.L., Baecher-Allan C., Maier L.M., Arthur A.T., Ottoboni L., Barcellos L., McCauley J.L., Sawcer S., Goris A., Saarela J., Yelensky R., Price A., Leppa V., Patterson N., de Bakker P.I., Tran D., Aubin C., Pobywajlo S., Rossin E., Hu X., Ashley C.W., Choy E., Rioux J.D., Pericak-Vance M.A., Ivinson A., Booth D.R., Stewart G.J., Palotie A., Peltonen L., Dubois B., Haines J.L., Weiner H.L., Compston A., Hauser S.L., Daly M.J., Reich D., Oksenberg J.R., Hafler D.A. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5264-5269.
11. Fogdell A., Hillert J., Sachs C., Olerup O. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995, 46:333-336.
12. Goertsches R., Villoslada P., Comabella M., Montalban X., Navarro A., de la Concha E.G., Arroyo R., Lopez de Munain A., Otaegui D., Palacios R., Perez-Tur J., Jonasdottir A., Benediktsson K., Fossdal R., Sawcer S., Setakis E., Compston A. A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. J. Neuroimmunol. 2003, 143:124-128.
13. Grütter M.G. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol. 2000, 10:649-655.
14. Refining genetic associations in multiple sclerosis. Lancet Neurol. 2008, 7:567-569. International Multiple Sclerosis Genetics Consortium (IMSGC).
15. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 2009, 10:11-14. International Multiple Sclerosis Genetics Consortium (IMSGC).
16. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862. International Multiple Sclerosis Genetics Consortium.
17. Kroner A., Mehling M., Hemmer B., Rieckmann P., Toyka K.V., Mäurer M., Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 2005, 58:50-57.
18. Kumar S., Vaux D.L. Apoptosis. A Cinderella caspase takes center stage. Science 2002, 297:1290-1291.
19. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schütze S., Peter M.E., Chan A.C. The role of receptor internalization in CD95 signaling. EMBO J. 2006, 25:1009-1023.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
21. Maas K., Chan S., Parker J., Slater A., Moore J., Olsen N., Aune T.M. Cutting edge: molecular portrait of human autoimmune disease. J. Immunol. 2002, 169:5-9.
22. Mandel M., Gurevich M., Pauzner R., Kaminski N., Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 2004, 138:164-170.
23. Marques-Bonet T., Lao O., Goertsches R., Comabella M., Montalban X., Navarro A. Association Cluster Detector: a tool for heuristic detection of significance clusters in whole-genome scans. Bioinformatics 2005, 21(Suppl 2):ii180-ii181.
24. Morcillo-Suarez C., Alegre J., Sangros R., Gazave E., de Cid R., Milne R., Amigo J., Ferrer-Admetlla A., Moreno-Estrada A., Gardner M., Casals F., Pérez-Lezaun A., Comas D., Bosch E., Calafell F., Bertranpetit J., Navarro A. SNP Analysis To Results (SNPator): a web-based environment oriented to statistical genomics analyses upon SNP data. Bioinformatics 2008, 24:1643-1644.
25. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
26. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le Page E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sørensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sá M., Salemi G., Savettieri G., Hillert J., Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151.
27. Salvesen G.S. Caspases and apoptosis. Essays Biochem. 2002, 38:9-19.
28. Sharief M.K. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis. J. Neuroimmunol. 2000, 109:236-243.
29. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
30. Stephens M., Smith N., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
31. Zipp F. Apoptosis in multiple sclerosis. Cell Tissue Res. 2000, 301:163-171.